Literature DB >> 16691112

The pathogenesis of multiple sclerosis: relating human pathology to experimental studies.

Samuel K Ludwin1.   

Abstract

Multiple sclerosis (MS) is a complex disease of unknown etiology. A careful study of the pathology of its component elements in relation to relevant experimental models has helped to understand some of the mechanisms that might be present in the disease. However, the autoimmune nature of the disease has recently come under question and there is a growing recognition of the importance of axonal, cortical, and white matter changes in the genesis and evolution of the lesions, their clinical diagnostic characteristics, and their response to treatment. This review highlights the emerging issues in MS from experimental, imaging and clinical perspectives.

Entities:  

Mesh:

Year:  2006        PMID: 16691112     DOI: 10.1097/01.jnen.0000225024.12074.80

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

1.  Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Authors:  Natalia M Moll; Anna M Rietsch; Smitha Thomas; Amy J Ransohoff; Jar-Chi Lee; Robert Fox; Ansi Chang; Richard M Ransohoff; Elizabeth Fisher
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

2.  Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation.

Authors:  Eva Herrero-Herranz; Luis A Pardo; Gertrude Bunt; Ralf Gold; Walter Stühmer; Ralf A Linker
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

3.  PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis.

Authors:  L Mestre; M Redondo; F J Carrillo-Salinas; J A Morales-García; S Alonso-Gil; A Pérez-Castillo; C Gil; A Martínez; C Guaza
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

Review 4.  The role of glial cells in multiple sclerosis disease progression.

Authors:  Luke M Healy; Jo Anne Stratton; Tanja Kuhlmann; Jack Antel
Journal:  Nat Rev Neurol       Date:  2022-02-21       Impact factor: 44.711

5.  Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis.

Authors:  Natalia M Moll; Michael B Cossoy; Elizabeth Fisher; Susan M Staugaitis; Barbara H Tucky; Anna M Rietsch; Ansi Chang; Robert J Fox; Bruce D Trapp; Richard M Ransohoff
Journal:  Arch Neurol       Date:  2009-01

Review 6.  Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.

Authors:  Patrizia Casaccia-Bonnefil; Giovanna Pandozy; Fabrizio Mastronardi
Journal:  Prog Neurobiol       Date:  2008-09-26       Impact factor: 11.685

Review 7.  Stem cells and neurological diseases.

Authors:  D C Hess; C V Borlongan
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

8.  Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.

Authors:  Abdulaziz Alshehri; Oun Al-Iedani; Jameen Arm; Neda Gholizadeh; Thibo Billiet; Rodney Lea; Jeannette Lechner-Scott; Saadallah Ramadan
Journal:  Neuroradiol J       Date:  2022-02-04

9.  Lipid biochemical changes detected in normal appearing white matter of chronic multiple sclerosis by spectral coherent Raman imaging.

Authors:  K W C Poon; C Brideau; R Klaver; G J Schenk; J J Geurts; P K Stys
Journal:  Chem Sci       Date:  2018-01-02       Impact factor: 9.825

10.  Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.

Authors:  Mario A Moscarello; Helena Lei; Fabrizio G Mastronardi; Shawn Winer; Hubert Tsui; Zhen Li; Cameron Ackerley; Li Zhang; Reinout Raijmakers; D Denise Wood
Journal:  Dis Model Mech       Date:  2012-11-01       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.